33,667
Views
127
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation

ORCID Icon, , , , , , , , & show all
Pages 975-989 | Received 25 Feb 2020, Accepted 19 Mar 2020, Published online: 30 Apr 2020